Neutrophil gelatinase associated lipocalin mRNA expression was detected at a higher rate in atherosclerotic tissue of patients with T2DM (in 19 of 20 patients, 95%) in comparison to non-diabetics (in 1 of 19 patients, 5%, p < 0.0001). The gene discussed is LCN2; the disease is type 2 diabetes mellitus.